Clinical Scorecard: Prostate Cancer Care: Advances in Risk Stratification, Imaging and Treatment

At a Glance

Key Highlights

• PSA testing is crucial for early diagnosis, especially in asymptomatic men.
• Multiparametric MRI enhances diagnosis and guides targeted biopsies.
• Focal therapy options allow for treatment of localized disease while preserving healthy tissue.
• PSMA imaging improves localization of disease and evaluation of recurrence.
• AI tools are emerging to assist in risk stratification and treatment selection.

Guideline-Based Recommendations

Diagnosis

• Use PSA testing as an entry point for risk assessment.
• Consider MRI for additional information when PSA or clinical factors raise concern.

Management

• Individualize treatment based on cancer risk, patient goals, and overall health.
• Consider observation for lower-grade, indolent disease.

Monitoring & Follow-up

• Utilize PSMA imaging for staging and recurrence evaluation post-therapy.

Risks

• Consider potential treatment-related urinary incontinence and erectile dysfunction.

Patient & Prescribing Data

Men diagnosed with prostate cancer, especially those with higher risk factors.

Minimally invasive techniques and individualized treatment plans are essential.

Clinical Best Practices

• Balance oncologic control with preservation of quality of life.
• Utilize advanced imaging techniques for accurate diagnosis and treatment planning.
• Incorporate AI tools to enhance risk assessment and treatment selection.

Related Resources & Content